Article Series on FTSG Meeting
July 3, 2012
![](https://www.theaftd.org/wp-content/plugins/bb-plugin/img/pixel.png)
Gabrielle Strobel writes a five-part series on the June 4 meeting of the Frontotemporal Degeneration Treatment Study Group (FTSG) held in Washington, DC. “Scientists Strategize with Regulators for Frontal Assault on FTD” is the first part of the series.
Part 2: Toward FTD Therapeutic Trials: Diagnosis Firm, Outcomes Still Soft
Part 3: Case Studies Crystallize Trial Ideas at FTD Conference
Part 4: Take It From the Agency: First FTD Drug May Be an Orphan
Part 5: For FTD Drug Development, a Q&A With Regulators
Click here to read all five parts in one document.
By Category
Our Newsletters
Stay Informed
![color-icon-laptop color-icon-laptop](/wp-content/uploads/2021/09/color-icon-laptop.png)
Sign up now and stay on top of the latest with our newsletter, event alerts, and more…